GLP-1及利拉肽整体介绍.pptVIP

  • 8
  • 0
  • 约7.43万字
  • 约 82页
  • 2019-03-07 发布于浙江
  • 举报
* * ADA=American Diabetes Association EASD=European Association for the Study of Diabetes AACE=American Assiciation of Clinical Endocrinologists ADA/EASD Odds Ratio Liraglutide 1.8 mg vs sitagliptin 100 mg 4.50 95% CI [2.90;6.97], p0.0001 Liraglutide 1.2 mg vs sitagliptin 2.75 95% CI [1.78;4.25], p0.0001 AACE Odds Ratio Liraglutide 1.8 mg vs sitaplitin 100 mg 4.25 95% CI [2.55;7.08], p0.0001 Liraglutide 1.2 mg vs sitagliptin 2.11 95% CI [1.24;3.59], p=0.0059 The estimates are from a logistic regression model with treatment as fixed effect and baseline HbA1c as covariate; 26 weeks after

文档评论(0)

1亿VIP精品文档

相关文档